Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001193805-13-002191
Filing Date
2013-12-02
Accepted
2013-12-02 15:51:46
Documents
1
Period of Report
2013-11-22

Document Format Files

Seq Description Document Type Size
1 e611599_4-shkreli.html 4  
1 e611599_4-shkreli.xml 4 4530
  Complete submission text file 0001193805-13-002191.txt   5927
Mailing Address 777 THIRD AVENUE 22ND FLOOR NEW YORK NY 10017
Business Address 777 THIRD AVENUE 22ND FLOOR NEW YORK NY 10017 212-983-1310
Retrophin, Inc. (Issuer) CIK: 0001438533 (see all company filings)

EIN.: 262383102 | State of Incorp.: DE | Fiscal Year End: 0229
SIC: 2834 Pharmaceutical Preparations

Mailing Address 330 MADISON AVENUE, 6TH FLOOR NEW YORK NY 10017
Business Address
Shkreli Martin (Reporting) CIK: 0001525354 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-53293 | Film No.: 131251816